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Abstract
Enteroaggregative E. coli (EAEC) is an established diarrhoeagenic pathotype. The
association with virulence gene content and ability to cause disease has been
studied but little is known about the population structure of EAEC and how this
pathotype evolved. Analysis by Multi Locus Sequence Typing of 564 EAEC isolates
from cases and controls in Bangladesh, Nigeria and the UK spanning the past 29
years, revealed multiple successful lineages of EAEC. The population structure of
EAEC indicates some clusters are statistically associated with disease or carriage,
further highlighting the heterogeneous nature of this group of organisms. Different
clusters have evolved independently as a result of both mutational and
recombination events; the EAEC phenotype is distributed throughout the population
of E. coli.
Introduction
The definition of EAEC varies in studies which either use its aggregative adherence
(AA) phenotype on HEp-2 cells [1], the CVD432 probe [2] or PCR to detect the
anti-aggregative transporter (aat) gene [3] or the EAEC regulatory gene (aggR) [4]
or a combination of phenotype and genotype. Enteroaggregative E. coli (EAEC)
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have been associated with diarrhoea in epidemiological studies and outbreaks.
Investigations of EAEC are based on identification of a group of bacteria (EAEC)
assumed to be pathogenic as they were isolated from symptomatic cases.
However, not all E. coli which contain EAEC virulence factors are pathogenic [5,6]
and so associations between EAEC and virulence are not clear. A comprehensive
study looking at the relationship between phylogeny from case or healthy carriage
in multiple countries has not been performed and there has been limited analysis
of EAEC at the population level. The most detailed study on EAEC population
analysis was in Nigeria and was carried out to find an association with EAEC
complexes and disease in children under 5 with links to virulence genes, resistance
and plasmid groups [7]. Results indicated that the range of sequence types (STs)
associated with EAEC is very large and disease, only within a specific age-group,
was linked to ST10, an ST associated with multiple E. coli pathotypes. There were
no reported associations between disease and, virulence genes, resistance profiles,
nor plasmid compatibility groups.
Serogrouping (typing of the somatic antigen only) and serotyping (typing of
the somatic and flagella antigen) is used extensively for characterising and
classifying E. coli and Salmonella enterica. For both species serogroup is not
discriminatory enough to be a useful strain typing tool but serotype can be more
robust. For Salmonella, serotype is strongly associated with sequence type [8].
Serotyping therefore can give a robust typing scheme although conversion
between serotypes can occur by horizontal genetic exchange [8] and so distort the
relationship within serotypes. The relationship between serotype and the EAEC
phenotype is not defined; here we describe a comprehensive examination of the
relationship between phylogeny/serotype/sequence type and whether the strain
was isolated from a patient with diarrhoea (case) or a healthy control.
We addressed the questions, are certain EAEC lineages more likely to be
associated with disease and have all EAEC evolved from a common ancestor? The
study used globally sourced EAEC isolates from three major case control studies
and analysed chromosomal core sequence data to look for an association between
bacterial background and disease.
Materials and Methods
Bacterial Strains
Three case control studies, sporadic and outbreak cases of 564 EAEC spanning
over 29 years (1985–2013) were used in this study (Table 1). All of these strains
were included to encompass a representation of EAEC in the global community
(including UK travellers) over the past three decades. EAEC were defined as
having the aat gene/CVD432 probe reaction [2,3], and/or the aggR regulatory
gene [6] and/or the aggregative adherence (AA) phenotype [1] where the
phenotypic test was available (Table 1). Isolates included strains from multiple
studies including the UK (273), Bangladesh (169), Nigeria (121) and the
Evolution of Enteroaggregative E. coli
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prototypical 042 EAEC reference strain from Peru (1) (Table 1). Due to the
varying definition of EAEC, all strains were included irrespective of phenotypic
and genotypic definition to prevent any bias that may affect the analysis. Where
an EAEC outbreak was related to one ST and serotype, only one representative
strain has been included.
Nigeria isolates were previously analysed [7] All other EAEC strains were plated
onto blood agar plates (PHE Media) to test for purity and archived onto Dorset
Eggs (PHE Media) and stored at room temperature and also archived on beads
[Prolab] and stored at 280 C˚.
Identification and Serotyping
Identification of UK and Bangladesh enteroaggregative Escherichia coli (EAEC)
strains (443 strains) was confirmed phenotypically using biochemical profiling of
media tubes [9] by the Gastrointestinal Bacteria Reference Unit of PHE at
Colindlae. Typical metabolic profiles of E. coli included positive reactions for
glucose, gas, lactose, mannitol, lysine, ornithine, mucate, sodium acetate and
indole. Serotyping of the somatic and flagella antigen [10] was carried out on the
heat stable lipopolysaccharide (Somatic or O) antigens and the flagellar (H)
antigens. Strains which reacted with all antigens were termed rough and those that
did not react with any were termed ‘O?’ or ‘H?’. Nigerian strains had previously
been identified and published [7], strains were not accessible for serotyping.
Table 1. Summary of 564 EAEC strains analysed in this study.
Country Source Year Range Case Control Reference
Peru ‘042 prototypical strain 1985 1 0 [27]
UK #GBRU Archive Clinical strains 1985–1995 17 0 This Study‘
UK ‘IID1 Case/Control Study 1993–1996 121 36 [28]
UK ‘GBRU Outbreak A 1994 2 0 [29]
UK ‘GBRU Outbreak B 1994 8 0 [29]
UK ‘GBRU Outbreak C 1994 1 0 [29]
UK ‘GBRU Outbreak D 1995 3 0 [29]
Bangladesh ‘GBRU Outbreak E 1998 12 0 This Study‘
Nigeria ‘Nigeria Case/Control Study 1999 66 55 [7]
UK #IID2 case study 2008–2009 25 0 [5]
Bangladesh ‘GEMS Case/Control Study 2007–2011 97 61 [30,31]
Germany #O104:H4 VTEC Outbreak 2011 1 0 [26]
UK #O111:H2 Household Outbreak 2012 1 0 [32]
UK #GBRU Clinical Strains 2009–2013 38 0 This Study‘
UK #GBRU Spice Outbreak 2013 19 0 [33]
Selection of EAEC strains used in this study including the year the strain was isolated and its geographical location. ‘Strains from this study not previously
described include archived clinical strains received by GBRU for typing between 1985–1995, Outbreak E of enteroaggregative E. coli that occurred in
Bangladesh in 1998, recent clinical strains received by GBRU for typing between 2009–2013. #EAEC were defined as having the aat and/or aggR gene.
‘Other EAEC strains were defined as having the aat gene/CVD432 probe reaction and/or the aggregative adherence (AA) phenotype.
doi:10.1371/journal.pone.0112967.t001
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Multi-locus sequence typing and analysis of EAEC
Nigerian sequence data was provided by Okeke et al as previously published [7].
Genomic DNA Extraction of all other E. coli isolates was carried out using the
Wizard Genomic DNA purification kit (Promega). PCR amplification of seven
Multilocus sequence typing (MLST) gene targets; adk, fumC, gyrB, icd, mdh, purA
and recA [11] was carried out followed by PCR purification of the amplicons
using the ExoSAP-IT PCR cleanup method (Amersham Biosciences UK Ltd).
Purified PCR fragments from the seven MLST gene targets were sequenced with
both forward and reverse sequencing primers using the ABI prism Bigdye
Terminator v3.1 Cycle Sequencing kit (Applied Biosystems) and detected and
analysed on the 3730XL ABI Genetic Analyser (Applied Biosystems). Sequence
data was analysed and checked for quality and alleles trimmed for analysis, any
ambiguous results were repeated (BioNumerics v6.1). Allele numbers and
sequence types (ST) were calculated and deposited in the publically accessible E.
coli MLST database (http://mlst.warwick.ac.uk.). Phylogenetic inference of the
EAEC complexes ancestral allelic profiles and strain interrelatedness were made
using minimum spanning trees (BioNumerics v6.1). A complex (Cplx) included
any single locus variants (SLV) of an allele in relation to a ST.
Selection of EAEC Disease and Carriage complexes and statistical
analysis
As of 18th December 2013, the data available in the public database indicates there
were 155 EAEC (121 Okeke et al Nigerian study used in this study excluded) out of
6110 E. coli entries, accounting for 2.4% of the database. There were 1164 entries
of defined diarrhoeagenic pathotypes (see below for description) of E. coli which
EAEC accounts for 13 % (155/1164). From the 564 strains used in this study, a
complex was considered a successful representation if it contained 4 or more
strains which would account for a minimum of 2.5% (4/155) of the known EAEC
deposited in the public database. The majority of the MLST data associated with
these isolates has been previously published [7,11].
From the EAEC dataset used in this study, complexes containing four or more
EAEC were deemed successful (i.e. strains which have continued to proliferate
over time in the population) of which there were 17 complexes. The 17 assigned
complexes were then tested using a fishers exact test [12] for the significance of
the complexes being associated with disease or carriage in relation to the entire
dataset (564 strains). Statistical tests of significance were conducted using the
Fisher’s exact test on Epi-Info version 2.3.1 (http://www.openepi.com).
The public database was compared against each of the 17 complexes to rule out
complexes with a high association with other pathotypes [11]. Pathotypes
included diarrheagenic types including enterotoxigenic, verocytotoxic, entero-
pathogenic, enteroinvasive and diffusely adherent E. coli (ETEC, VTEC, EPEC,
EIEC and DAEC respectively). Extra-intestinal pathogenic E. coli (ExPEC)
including wounds, meningitis, external sources (ExPEC_Vag) and urinary
pathogenic E. coli (UPEC). Antibiotic resistance E. coli (ESBL, CTX-M-15,
Evolution of Enteroaggregative E. coli
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NMEC, AmpC CYM-2, c CMY-2, NDM-1, ESBL CTX-M-32 & OXA-48). Other
pathotypes included avian pathogenic E. coli (APEC), non-pathogenic commensal
strains and E. coli with no defined pathotype. EAEC complexes were assessed
based on the public database and data from this study and tested using a fisher
exact test [12] (open epi version 2.3.1) for significance of the complexes being
associated with EAEC.
ClonalFrame Analysis
Clonal Frame analysis was carried out (http://www.xavierdidelot.xtreemhost.com/
clonalframe.htm) on all EAEC isolates to investigate the relationships of the
different sequence type complexes. ClonalFrame is a Bayesian method of
constructing evolutionary histories that takes both mutation and recombination
into account [13]. The Graphic User Interface in the ClonalFrame programme
was used to construct 75% majority-rule consensus trees, mutational (theta) and
recombination rates. Other analysis including the measure of the frequency at
which recombination occurs relative to mutation (r/h). The relative effect of
recombination on the genetic diversification of populations, ratio r/m in which
the ratio of rates at which nucleotides become substituted as a result of
recombination and mutation [14] was also used. Finally, the external to internal
branch length ratio was computed which gave the inferred expected values against
the coalescent and actual ratios. Analysis was split into assessing the Bangladesh
and Nigeria case control studies and UK clinical data set for comparison against
the entire dataset.
Placing EAEC in the E. coli phylogeny
Multi-locus sequence analysis (MLSA) was performed by concatenating MLST
sequence alleles of the EAEC from this dataset and all sequence types
representative of the E. coli phylogeny. These were aligned and clustered (MEGA
V 5.1) and the genetic relationship of isolates designated as was assessed in the
context of all E. coli using a neighbour joining tree phylogeny (MEGA V 5.1 and
FigTree V 1.4). Phylogrouping PCR was carried out on the 17 main groups of
EAEC [15] and labelled on the phylogeny.
Results
Serotype and complex distribution within the EAEC population
structure
From the 564 EAEC strains studied, there were 126 different sequence types,
including additional not previously described sequence types of which 57 were
single locus variants (SLV), 20 double locus variants (DLV) and two were triple
locus variants (TLV).
Evolution of Enteroaggregative E. coli
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There were 17 main complexes (Figure 1) containing 4 or more strains of
EAEC totalling 358 strains with the top five complexes (Cplx) including ST10
Cplx (39%, 141/358), ST31 Cplx and ST40 Cplx (12%, 42/358), ST394 Cplx (7%,
26/358) and ST295 Cplx and ST38 Cplx (6%,21/358). There were 35 isolates
(6.2%, 35/564) that contained one or more new alleles (40 new alleles in total) not
previously described. All new alleles were deposited to the public database (http://
mlst.ucc.ie/mlst/dbs/Ecoli) for a new allele and/or ST assignment.
Most EAEC serotypes were heterogeneous with respect to ST and dispersed
throughout the population structure (Figure S1): Some serotypes were
Figure 1. Minimal spanning tree of 564 enteroaggregative E. coli. Minimum spanning tree of the 564 EAEC used in this study colour coded by isolates
from cases (red) and controls (yellow). Complexes shaded in grey consist of single locus variants (SLV). Sequence types and complex (Cplx) are labelled as
numbers.
doi:10.1371/journal.pone.0112967.g001
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predominantly associated with STs (O7:H4-ST484, O104:H4-ST678, O111:H21-
ST40, O125ac:H9-ST295, O153:H30-ST38,) while others were found in multiple
STs (O44:H18-ST449, ST414, ST30, O126:H27-ST200 & SLV, ST155, O166:H15-
ST349 & SLV/DLV, ST130, ST394,). There were no mutually exclusive ST and
serotypes found in the EAEC population structure (Table S1).
EAEC complexes associated with disease and carriage
The population structure of EAEC was heterogeneous containing 17 complexes
(either single ST or complexes) of successful lineages containing 4 or more EAEC
(Figure 1, Table 2).
There was a 2.71 ratio of case isolates to controls in this study. Complexes with
a higher ratio in cases were deemed associated with cases and complexes with a
higher ratio in controls were deemed associated with controls, complexes that
were below this ratio were deemed to be not associated with cases or controls.
This resulted in eleven complexes being associated with disease (ST10, 30, 40, 155,
165, 278, 501, 678, 720, 746 and 1891, Cplx), two complexes associated with
carriage (ST31 and 349 Cplx) and four complexes neither associated with disease
or carriage (ST,38, 168, 295 and 394 Cplx).
The disease complexes and carriage complexes were combined and statistical
analysis showed both of the disease and carriage complexes were statistically
significant (P5,0.001 and P50.001 respectively) (Table 2).
Individual complexes were then tested for statistical association with disease or
carriage which showed ST10 Cplx and ST40 Cplx were independently statistically
significantly (P50.01 & 0.03 respectively) associated with disease. ST31 was
independently statistically significantly (Fishers chi-square, p50.005) associated
with carriage (due to the fact that there was a higher ratio of controls).
Situating the 17 successful EAEC complexes identified in this study within the
global E. coli phylogeny as represented in the public database (Table 3) showed
that with the exception of ST155 Cplx, all complexes were significantly associated
with being EAEC pathotype (P#0.01).
Evolutionary Events leading to successful EAEC disease complexes
ClonalFrame analysis showed that EAEC mutation and recombination rates varied
across the complexes and Countries (Table 4 & 5). Complex ST10 Cplx had the
highest mutation rate (4.05) and recombination rate (1.2) whereas ST295 Cplx the
lowest mutation rate (0.02) and lowest recombination rate (0.002). However, both
of these complexes had a similar mutation to recombination ratio. Recombination
had the greatest impact (on the diversification of the lineages) on ST40 Cplx (12)
and ST394 Cplx (10). Recombination occurred 1.7 times more often than
mutation rate among isolates from Bangladesh and Nigeria whereas among strains
isolated in the UK, recombination and mutation rate was almost equal. The entire
dataset recombination events occurred 1.3 times more often than mutational events.
Evolution of Enteroaggregative E. coli
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The geographical location of the place of isolation of an EAEC strain bears no
significance in its phylogeny grouping (with the exception of small geographical
specific STs possibly due to sampling bias) and successful EAEC ST were distributed
globally (Figure S2) The impact of recombination in the diversification of the
sample set relative to mutation showed the greatest impact in the Bangladesh strain
set, and the least impact in the strains from the UK. This data suggest that
recombination may play an important role in the evolution of EAEC (Table 4 & 5).
External to Internal Branch Length Ratio gave coalescent expectations
indicating that all EAEC irrespective of location and including the entire dataset
were significantly different (p5,0.001) from the inferred value (Table 4).
Evolution of EAEC in the context of the E. coli population
Of the five main branches of E. coli phylogeny, EAEC are most prominent on
branches 1, 2 and 3 (Figure 2) consisting of phylogroups D, A and B1 respectively.
ST30, 31, 38, and 394 Cplxs which are grouped together by MLST population
structure (Figure 1) are all located on branch 1 of the E. coli phylogeny. The other
large successful complexes are dispersed throughout branch 2 and 3. ST10 Cplx
shows that some SLVs on the MLST structure are separate in the context of the
Table 2. Assessment of EAEC complexes associated with cases or controls.
Group ST complex UK Nigeria Bangladesh Case Control Total Total % of EAEC CASE: CONTROL % P Value
Group 1 10 128 24 21 138 35 173 30.7 8020 0.01
Group 2 40 39 1 12 44 8 52 9.2 8515 0.03
Group 3 31 27 11 12 28 22 50 8.9 5644 0.005
Group 4 295 13 2 21 24 12 36 6.4 6733 0.24
Group 5 38 3 4 21 19 9 28 5.0 6832 0.33
Group 6 394 9 10 8 20 7 27 4.8 7426 0.56
Group 7 746 9 1 1 10 1 11 2.0 9010 0.16
Group 8 155 0 1 9 9 1 10 1.8 9010 0.2
Group 9 678 8 0 2 9 1 10 1.8 9010 0.2
Group 10 278 7 1 2 9 1 10 1.8 9010 0.2
Group 11 168 (ST484) 0 4 5 5 4 9 1.6 5644 0.2
Group 12 30 7 0 0 8 0 8 1.4 1000 0.08
Group 13 165 3 0 5 7 1 8 1.4 8317 0.32
Group 14 1891 0 0 5 4 1 5 0.9 8020 0.59
Group 15 720 0 0 5 5 0 5 0.9 1000 0.21
Group 16 501 2 2 0 3 1 4 0.7 7525 0.71
Group 17 349 0 1 3 1 3 4 0.7 2575 0.06
Totals - 248 62 132 343 107 442 - - -
Whole Data Set - 273 121 169 412 152 564 - - -
Assessment of the successful EAEC complexes (.4 strains) as to the association with cases or controls and showing the data of EAEC numbers according
to complex size, Country and association with case or control. Groups are in order of complex size from the largest to smallest. Probability (Fishers exact
test) of the group being significantly associated with case or control is tabulated at the end.
doi:10.1371/journal.pone.0112967.t002
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E. coli phylogeny though still closely related. ST295 Cplx which is linked to ST10
Cplx by ST48 is on the opposite end of branch 2 and therefore evolutionary distant. The
smaller successful complexes with only 4 EAEC were found at the end of branch 4
which contained a mixture of phylogroups A and D. None of the main EAEC
Table 4. Mutation and Recombination rates of dataset by geographical source and all Sequence types found in dataset.
Parameters
Bangladesh N5169
(108 Cases, 61
Controls)
Nigeria N5121 (66
cases, 55 controls)
UK N5254 (228
cases, 36 controls)
All ST N5199 (138
cases, 61
controls)
Mutation Rate (theta 0) Mutational rate & assumed to be
constant on the branches of topology
mean: 15.03, credi-
bility_region: 6.95–
26.14
mean: 120.79, cre-
dibility_region:
69.29–33.00
mean: 70.13, credi-
bility_region: 49.35–
94.01
mean: 16.01, credi-
bility_region: 8.64–
23.71
Recombination rate (R) recombination rate & assumed
constant on branches of topology
mean: 22.58, credi-
bility_region: 14.05–
33.46
mean: 31.38, credi-
bility_region: 19.68–
43.37
mean: 15.66, credi-
bility_region: 9.84–
22.31
mean: 89.53, credi-
bility_region 64.21–
121.96
view rho over theta (p/0) How often recombination occurs
relative to mutations
mean: 1.65, credibi-
lity_region: 0.77–
3.14
mean: 1.68, credibi-
lity_region: 0.78–
3.80
mean: 1.048907,
credibility_region:
0.50–1.987
mean: 1.317856,
credibility_region:
0.76–2.07
view r over m (r/m) The impact of how important the effect of
recombination was in the diversification of the sample relative
to mutation
mean: 4.38, credibi-
lity_region: 2.38–
8.05
mean: 4.10, credibi-
lity_region: 2.13–
8.09
mean: 2.60, credibi-
lity_region: 1.44–
4.39
mean: 2.87, credibili-
ty_region 1.94–
4.24
External to Internal Branch Length Ratio Gives the inferred
expected values against the coalescent and actual rations. It
they are significantly apart then it shows there was a genetic
event such as recombination that led to these values.
mean: 0.73, interval:
0.54–0.94
Significance: 0.00
mean: 0.56, interval:
0.40–0.76
Significance: 0.01
mean: 0.67, interval:
0.50–0.88
Significance: 0.00
mean: 0.90, interval:
0.72–1.06
Significance: 0.00
ClonalFrame mutation and recombination rates shown as well the impact of recombination over mutation in the diversification of the data and also the
significance of the expected value over the inferred value as to whether the data evolved over a period of time (not significant) or due to a large genetic event
(significant). This analysis was applied to the different geographical locations, and all 564 EAEC ST found in this study.
doi:10.1371/journal.pone.0112967.t004
Table 5. Mutation and Recombination rates of dataset by ST complex.
Parameters ST10 Cplx & DLV ST38 Cplx & DLV ST40 Cplx & DLV ST295Cplx & DLV ST394Cplx & DLV
ST31 & ST 130Cplx &
DLV
Mutation Rate
(theta 0)
mean: 4.04, credibi-
lity_region: 2.097–
6.31
mean: 0.28, credibi-
lity_region: 0.02–
1.00
mean: 0.94, credibi-
lity_region: 0.02–
2.62
mean: 0.02, credibi-
lity_region: 0.00–
1.87
mean: 0.23, credibi-
lity_region: 0.00–
1.00
mean: 0.65, credibili-
ty_region:0.13–1.48
Recombination
rate (R)
mean: 1.24, credibi-
lity_region: 0.41–
2.84
mean: 0.08, credibi-
lity_region: 0.00–
0.38
mean: 0.61, credibi-
lity_region: 0.00–
1.90
mean: 0.00, credibi-
lity_region: 0.00–
0.01
mean: 0.10, credibi-
lity_region: 0.00–
0.46
mean: 0.37, credibili-
ty_region: 0.03–0.97
view rho over
theta (p/0)
mean: 0.33, credibi-
lity_region: 0.09–
0.82
mean: 0.68, credibi-
lity_region: 0.00–
3.60
mean: 5.55, credibi-
lity_region: 0.00–
46.86
mean: 0.57, credibi-
lity_region: 0.00–
4.49
mean: 4.07, credibi-
lity_region: 0.00–
33.12
mean: 1.07, credibili-
ty_region: 0.04–5.63
view r over m (r/
m)
mean: 1.20, credibi-
lity_region: 0.39–
2.66
mean: 3.55, credibi-
lity_region: 0.01–
19.63
mean: 12.00, credi-
bility_region: 0.00–
102.35
mean: 0.91, credibi-
lity_region: 0.00–
7.04
mean: 10.39, credi-
bility_region: 0.00–
74.56
mean: 4.27, credibili-
ty_region: 0.24–
20.06
External to
Internal Branch
Length Ratio
mean: 0.48, inter-
val:0.28–0.72
Significance:0.02
mean: 0.77, inter-
val:0.30–1.51
Significance:0.15
mean: 0.64, inter-
val:0.30–1.20
Significance:0.09
mean: 0.64, inter-
val:0.29–1.25
Significance:0.15
mean: 0.64, inter-
val:0.23–1.32
Significance:0.24
mean: 0.56, inter-
val:0.27–1.143
Significance:0.12
ClonalFrame mutation and recombination rates shown as well the impact of recombination over mutation in the diversification of the data and also the
significance of the expected value over the inferred value as to whether the data evolved over a period of time (not significant) or due to a large genetic event
(significant). This analysis was applied to the large main complexes including single locus variants (SLV) and double locus variants (DLV).
doi:10.1371/journal.pone.0112967.t005
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complexes (Table 2) were found in branch 5 of the E coli phylogeny which is generally
associated with extra-intestinal infections such as ST131 belonging to phylogroup B2.
Discussion
Serotyping does not always correlate with genetic relatedness and
cannot be used to infer genetic background
Although there were serotypes exclusively from cases (O3:H2, O44:H18, O104:H4,
O111:H21, O126:H27and O134:H27), In this study we found no link between a
Figure 2. Neighbour joining tree of all E. coli and enteroaggregative E. coli in this study. Neighbour joining tree of concatenated MLVA of the 564
EAEC used in this and all STacross the E. coli population structure. Phylogeny is separated into four main branches. EAEC is distributed throughout the E.
coli phylogeny as shown in branches 1–4 containing phylogroups, A, B1 and D. The main EAEC complexes was not found in branch 5, phylogroup B2
associated with extra-intestinal infections.
doi:10.1371/journal.pone.0112967.g002
Evolution of Enteroaggregative E. coli
PLOS ONE | DOI:10.1371/journal.pone.0112967 November 21, 2014 11 / 17
sequence type and a single serotype Although some serotypes were associated with
single clonal complexes, they were not mutually exclusive and high recombination
rates in some lineages meant that a given serotype could also be distributed in
different complexes (Figure S1, Table S1).
Since the development of sequence based typing, such as MLST, the use of
traditional typing methods, such as serotyping as a means of population
structure [16,17] have come under close scrutiny. Other studies have also shown
that the same serogroups are found in genetically unrelated strains of E. coli
indicating possible horizontal gene transfer [18] of the cassette encoding the
serogroup genes. In this study we were looking for lineages of EAEC and so we
used MLST as the primary typing method. and we conclude, as others have, that
serotyping is not a suitable method for determining ancestral relatedness of
EAEC.
There are successful multiple lineages of EAEC complexes that
are globally distributed
We have shown a statistically significant association of certain sequence type
complexes of enteroaggregative E. coli with disease or carriage. These complexes
represent independent lineages which were spread throughout the entire E. coli
population (Figure 2) and included the EAEC published complexes in the public
database: ST10 Cplx, ST40 Cplx, ST38 Cplx, ST394 Cplx and ST349 Cplx [7].
Prototypical EAEC strains 042 (from Peru) and 17–2 (from Chile) belong to ST31
Cplx and ST10 Cplx respectively, which were prominent in this study. This study
also identified MLST complexes that were not currently represented in the public
database as associated with the aggregative phenotype including ST130 Cplx,
ST295 Cplx, ST484 Cplx, ST678 and ST720 Cplx. This data represents a snapshot
of EAEC, from three different countries, and the addition of strains across the
globe will expand the number STs associated with EAEC. It should be noted that
the public database is biased towards E. coli of clinical interest such as pathogenic
and antibiotic resistant strains with little representation of commensal strains
and it is likely that not all isolates were tested for the aggregative phenotype. A
larger, better defined, population of E. coli as a whole is needed to
comprehensively define the distribution of EAEC in MLST complexes.
Although there are some MLST complexes/STs restricted to one country, these
contain small numbers and all of the complexes with larger numbers of isolates
are distributed throughout the phylogeny indicating a global distribution of the
major clusters (Figure S2) most likely due to human travel. The independent
appearance of the EAEC phenotype in discrete complexes across phylogeny
(homoplasy), supports the observation of others [19] and suggests convergent
evolution - the EAEC phenotype therefore confers a biological advantage in
certain bacterial genetic backgrounds.
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Multiple genetic events have led to the independent evolution of
EAEC
In order to understand the genetic events which led to the formation of different
EAEC associated MLST complexes Clonal Frame analysis of the branching events
for each node was carried out. Variation in the frequency of recombination or
mutation which occurred in all of the seven loci at different time points was seen
indicating multiple genetic events over time. The relative frequency of
recombination as compared to mutation (r/h) for the entire data set was 1.31 and
is comparable to the rates proposed by Wirth et al [11] and Touchon et al [20] but
higher than computed rates for the E. coli species via MLST including those that
estimated recombination at approaching zero [21].
The parameters of rates and impact are based on the Markov model [22] which
assumes that horizontal gene transfer events are equally probable between any pair
of lineages, irrespective of phylogenetic and ecological proximity [23]. Our
analysis clearly showed that this isn’t the case and that (in this dataset)
recombination rates vary within the EAEC pathotype between different lineages,
the most ancestral being ST10 Cplx with the least impact of recombination in
comparison to the other lineages (Table 5).
Multiple successful complexes (Figure 1) vary in mutation and recombination
rate (Table 4) and are distributed throughout the E. coli population (Figure 2).
These complexes have clearly evolved independently through multiple genetic
events that have led to the phenotypic congruency of this pathotype. The selection
of strains with a biological advantage has resulted in different, apparent,
mutation/recombination rates suggests that certain bacterial backgrounds allow
the advantage to be expressed - possibly influenced by the ability to retain the
EAEC plasmid. Fast radiation of the complexes after population bottlenecks and
frequent recombination seems a likely explanation for this pattern [11]. This may
explain why the main gastrointestinal EAEC complexes were not found in the
extra-intestinal E. coli phylogeny branch.
Evolutionary events of EAEC
Although EAEC strains share the common phenotype of aggregative adherence,
this and earlier research (Okeke et al 2010) demonstrates that the phenotype is
convergent - has arisen in different lineages and been selected by survival in the
human host. The selective advantage of aggregative adherence would allow EAEC
strains to colonize the human gut during episodes of diarrhoea from other causes
Lineages of EAEC found to be non-pathogenic are possibly strains that have
developed exceptional colonization ability but not the ability to actually cause
disease. Other lineages however, are associated with the ability to cause disease.
Outbreak investigations and the strong association of some lineages with disease
in this study point to multiple EAEC, but distinct, lineages that cause disease.
Distinct sub-populations within a species may emerge because of differential local
adaptation or genetic drift [14]. This concept may be applied to successful EAEC
complexes which represent clusters of closely related genotypes and can be termed
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ecotypes [24] and will differ in their homologous recombination events because of
adaptive evolution or environmental constraints [14]. This is supported by the
variable recombination rate in different complexes which may have evolved from
different environments. The variable recombination rate from each country will
depend on the complexes found from the sample size tested. For EAEC isolates
from UK residents the low impact of recombination may be because EAEC
infection is related to travel and would therefore include EAEC found in multiple
countries.
Virulent pathotypes have been shown to recombine more than non-pathogens
pointing towards the theory that that virulence is the driving force for more
frequent recombination [11]. This is shown with ST40 Cplx which is statistically
associated with disease (p50.03) and had the highest impact of recombination on
diversification. However ST10 Cplx, also statistically associated with disease
(p50.01), had the highest rate of mutation among the complexes and the impact
of recombination was almost equal to mutation (11.2). This indicates that both
types of genetic events are important in the evolution of pathogenic EAEC but
that local variation occurs.
Our data analysis of the concatenated MLST sequences showed that the external
to internal branch length ratio of the phylogeny was significantly higher than
expected (Table 4). This means that the inferred genealogy is consistent with an
expansion of the population size by acquisition of a fitness advantage early in the
history of the sample [22]. For example, one suggestion is that the ancestral ST10
Cplx already had the background mutations to be able to acquire and retain the
EAEC plasmid and so the external to internal branch length ratio is as expected.
This fits in with previous studies where a specific genetic background is required
to acquire and express virulence factors in E. coli [25]. Other complexes with
unexpected external to internal branch length ratio, such as ST40 Cplx, needed
recombination and/or mutation events to allow the stable retention of the
advantageous EAEC plasmid. A recently reported example of how acquisition of
this EAEC plasmid can increase fitness is the ST678 (O104) VTEC German
outbreak [26]. This is a VTEC strain that didn’t have the characteristic eae gene
(attachment and effacement loci for intimate adherence) but did have the plasmid
encoded aat gene cluster associated with adherence. This strain was particularly
virulent, with high HUS rates, but had the same toxin type as many other VTEC
strains, the difference, presumably, being its strong ability to adhere and hence
introduce more toxin. This basic mechanism of attachment could be the fitness
advantage that this relatively new pathotype, EAEC, has harboured and then
successfully expanded.
Conclusions
This study has clearly shown the complexity of the evolution of EAEC, while it is
evident that the same lineages prevail in multiple global locations, indicative of
clonal expansion, whilst other lineages are ecologically adapting through a process
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of convergent evolution. This would account for the inconsistent impact rates of
recombination between different geographical locations and different complexes.
The collection of organisms given the ‘‘pathotype’’ EAEC has evolved as multiple
independent lineages with some complexes associated with disease, but not all.
This is important as a non-disease causing EAEC still has the ability to acquire
other virulence factors and the combination of aggregative adherence and
virulence can cause severe outbreaks. The presence of the aggR genes as an
indicator of aggregative adherence ability should therefore be considered when
diagnosing gastrointestinal disease.
Supporting Information
Figure S1. Minimal Spanning Tree of 443 enteroaggregative E. coli serotyped.
Minimum Spanning Tree of 443 EAEC serotyped in this study. Tree is colour
coded by serotypes containing 3 or more isolates. Serotypes shown in one or two
strains were coloured white. Complexes shaded in grey consist of single locus
variants (SLV). Sequence types are labelled as numbers.
doi:10.1371/journal.pone.0112967.s001 (TIF)
Figure S2. MSTree Geographical location. Minimal spanning tree of the 564
EAEC used in this study colour coded by isolates from Bangladesh (red), Nigeria
(purple) and UK (green) and the prototypical O42 strain from Peru (yellow).
Complexes shaded in grey consist of single locus variants (SLV). Trees shows that
complexes are mainly distrusted in at least two countries with only a few small
complexes and singletons geographically specific. Sequence types and complex
(Cplx) are labelled as numbers.
doi:10.1371/journal.pone.0112967.s002 (TIF)
Table S1. Strain list used in this study. Table of strains used in this study listing
the year the strain was isolated, the Country the strain was isolated from, somatic
and flagella typing results (serotyping), sequence type and complex the strain
belongs to. NT: Not tested, Novel sequence types consisted of either single locus
variants (SLV), double locus variants (DLV) or triple locus variants (TLV) of
known sequence types.
doi:10.1371/journal.pone.0112967.s003 (PDF)
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